Aim Chromosome translocations are considered as one of the most severe forms of genome defects. Because of the clinical significance of chromosome translocations and scarce data on the incidence of sporadic translocations in population of Bosnia and Herzegovina, we aimed to report sporadic translocation frequencies in samples karyotyped in our laboratory. Methods The study group consisted of 108 samples. Whole blood was cultivated in complete medium for 72 hours with the thymidine application at 48th hour to synchronize the cell culture. Metaphases were arrested by colcemid 60 minutes before harvesting. Following hypotonic treatment, cells were fixed and cell suspension was dropped on coded slides. Dried slides were subjected to conventional GTG (G-banding with trypsin-Giemsa) banding and analyzed under 1000x magnification in the accordance with ISCN (International System for Human Cytogenetic Nomenclature) and E.C.A. Cytogenetic Guidelines and Quality Assurance. Results The incidence of all detected sporadic translocations was 27.81 x 10-4 per metaphase. The incidence of sporadic translocations involving chromosomes 7 and 14, being considered as the most frequent sporadic translocations of the human karyotype in phytohaemagglutinin (PHA) stimulated lymphocytes, was 15.89 x 10-4 per metaphase. The most frequent breakpoints were 7p21, 14q11 and 14q21. Other detected sporadic translocation breakpoints were: 1q25, 3p22, 7p13, 7q11.22, 7q33, 14q23 and 19q13.4. Conclusion Higher incidence of sporadic translocations compared to the similar studies was registered. Since potential explanations for this issue are smaller sample size and higher exposure of examined population to genotoxic agents, further monitoring of sporadic translocation incidences is recommended.
Krunić A, Haverić S, Ibrulj S. Micronuclei frequencies in peripheral blood lymphocytes of individuals exposed to depleted uranium. Arh Hig Rada Toksikol 2005:227–32.
2
Kamnasaran D, Cox D. Current status of human chromosome 14. J Med Genet 2002:81–90.
3
Rowley J. Chromosome translocations: dangerous liaisons revisited. Nat Rev Cancer 2001:245–50.
4
Bozkurt S, Okay M, Saglam F, Haznedaroglu I. Retrospective evaluation of chromosome 1 anomalies in hematologic malignancies: a single center study. Genetics and Applications 2019:17–24.
5
Klein I, Resch W, Jankovic M, Oliveira T, Yamane A, Nakahashi H, et al. Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell 2011:95–106.
6
Chiarle R, Zhang Y, Frock R, Lewis S, Molinie B, Ho Y, et al. Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell 2011:107–19.
7
Baccarelli A, Hirt C, Pesatori A, Consonni D, Patterson D, Bertazzi P, et al. 2006:2001–7.
8
Zeljezic D, Vrdoljak A, Lucas J, Lasan R, Fucic A, Kopjar N, et al. Effect of occupational exposure to multiple pesticides on translocation yield and chromosomal aberrations in lymphocytes of plant workers. Environ Sci Technol 2009:6370–7.
9
Tucker J. Chromosome translocations and assessing human exposure to adverse environmental agents. Environ Mol Mutagen 2010:815–24.
10
Ibrulj S, Haverić S, Haverić A. Chromosome aberrations as bioindicators of environmental genotoxicity. Bosn J Basic Med Sci 2007:311–6.
11
Besic L, Muhovic I, Asic A, Kurtovic-Kozaric A. Meta-analysis of depleted uranium levels in the Balkan region. J Environ Radioact 2017:207–17.
12
Ibrulj S, Haverić S, Haverić A, Durmić-Pasić A, Marjanović D. Effect of war and postwar genotoxins on micronuclei frequency in Sarajevo study group. Bosn J Basic Med Sci 2006:54–7.
13
Meaburn K, Misteli T, Soutoglou E. Spatial genome organization in the formation of chromosomal translocations. Semin Cancer Biol 2007:80–90.
14
Hecht F, Hecht B, Kirsch I. Fragile sites limited to lymphocytes: molecular recombination and malignancy. Cancer Genet 1987:95–104.
15
Hastings R, Howell R, Bricarelli F, Kristoffersson U, Cavani S. General guidelines and quality assurance for cytogenetics: a common European framework for quality assessment for constitutional, acquired and molecular cytogenetic investigations 2012.
16
Shaffer L, Tommerup N, Iscn. An International System for Human Cytogenetic Nomenclature 2005.
17
Hillier L, Fulton R, Fulton L, Graves T, Pepin K, Wagner-Mcpherson C, et al. The DNA sequence of human chromosome 7. Nature 2003:157–64.
18
Reddy K, Thomas I. Significance of acquired nonrandom 7/14 translocations. Am J Med Genet 1985:305–10.
19
Dewald G, Noonan K, Spurbeck J, Johnson D. T-Lymphocytes with 7;14 Translocations: frequency of occurrence, breakpoints, and clinical and biological significance. Am J Hum Genet 1986:520–32.
20
O’connor C. Human chromosome translocations and cancer. Nature Education 2008:56.
21
Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nat Rev Cancer 2007:233–45.
22
Livingston G, Ryan T, Smith T, Escalona M, Foster A, Balajee A. Detection of simple, complex, and clonal chromosome translocations induced by internal radioiodine exposure: a cytogenetic followup case study after 25 Years. Cytogenet Genome Res 2019:169–81.
23
Qaqish B, Al-Dalahmah O, Al-Motassem Y, Battah A, Ismail S. Occupational exposure to pesticides and occurrence of the chromosomal translocation t(14;18) among farmers in Jordan. Toxicol Rep 2016:225–9.
24
Dudley D, Chaudhuri J, Bassing C, Alt F. Mechanism and control of V(D) J recombination versus class switch recombination: similarities and differences. Adv Immunol 2005:43–112.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.